Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study

AstraZeneca

Status: Completed

Conditions: Metastatic Breast Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT01715155

NIS-OBG-XXX-2012/1

Details and patient eligibility

About

The purpose of this study is to evaluate the incidence rate of progression of disease, to describe the diagnostic and clinical management in patients with Metastatic Breast Cancer in the clinical practice in Bulgaria.

Full description

A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in Clinical Practice in Bulgaria

Enrollment: 171 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• New diagnosis of breast cancer according to ICD-10 with confirmed metastasis
• Confirmed diagnosis between 1st July 2010 and 30th June 2011.
• Female patient managed for her disease at the same setting where final diagnosis of MBC was performed.

Exclusion criteria

• History of concurrent or other primary malignancies (except curatively resected non-melanoma skin cancer or in situ cervical cancer).

Trial design

171 participants in 1 patient group

Female patients diagnosed with metastatic breast cancer

Description:

Patients newly diagnosed with metastatic breast cancer, either De Novo or having progressed from a non-metastatic stage.